Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells

Clinical and Experimental Immunology

Volumn 116, Issue 3, 1999, Pages 435-440

  Weiss, G ^a   Murr, C ^b   Zoller, H ^a   Haun, M ^a   Widner, B ^b   Ludescher, C ^a   Fuchs, Dietmar ^b,c  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c Institute for Medical Chemistry and Biochemistry   (Austria)

Author keywords

Interferon gamma; Macrophages; Neopterin; Tryptophan degradation

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; NEOPTERIN; TRYPTOPHAN;

ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

CELL LINE; CYTOKINES; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; MONOCYTES; NEOPTERIN; TH1 CELLS; TH2 CELLS; TRYPTOPHAN;

EID: 0033066772     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00910.x     Document Type: Article

References (28)

1. Huber C, Batchelor JR, Fuchs D et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon gamma. J Exp Med 1984; 160:310-6.
2. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Yim JJ, Pfleiderer W, Wachter H. Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells. J Biol Chem 1990; 265:3189-92.
3. Byrne G, Lehmann LK, Kirschbaum JG, Borden EC, Lee CM, Brown RR. Induction of tryptophan degradation in vitro and in vivo. A gamma-interferon stimulated activity. J Interferon Res 1986; 6:389-98.
4. Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, Dierich MP, Wachter H. Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci 1987; 41:273-80.
5. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment. Cancer Res 1990; 50:2863-7.
6. Gasse T, Widner B, Baier-Bitterlich G, Sperner-Unterweger B, Leblhuber F, Wachter H, Fuchs D. Abnormal tryptophan metabolism, neurologic/psychiatric disturbances and its relationship to immune activation In: Qureshi GA, Parvez H, Caudy P, Parvez S, eds. Progress in HPLC-HPCE, Vol. 7. Neurochemical markers of degenerative nervous diseases and drug addiction; Utrecht: VSP, 1998:351-82.
7. Schröcksnadel H, Baier-Bitterlich G, Dapunt O, Wachter H, Fuchs D. Decreased plasma tryptophan in pregnancy. Obstet Gynecol 1996; 88:47-50.
8. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today 1988; 9:150-5.
9. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Neopterin as a marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989; 27:81-141.
10. Fahey JL, Taylor JMG, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV. The prognostic value of cellular and prognostic markers in infections with human immunodeficiency virus type I infection. N Engl J Med 1990; 322:166-72.
11. Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use a marker for cellular immune reactions. Int Arch Allergy Immunol 1993; 101:1-6.
12. Fuchs D, Malkovsky M, Reibnegger G, Werner ER, Forni G, Wachter H. Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Immunol Letters 1989/90; 23:103-8.
13. Fuchs D, Hausen A, Reibnegger G, Werner-Felmayer KG, Dierich MP, Wachter H. Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type. 1. J Acquir Immune Defic Syndr 1989; 2:158-62.
14. Denz H, Fuchs D, Huber H, Nachbaur D, Reibnegger G, Thaler J, Werner ER, Wachter H. Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Eur J Haematol 1990; 44:186-9.
15. Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner ER, Wachter H. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and neurologic/psychiatric symptoms. J Acquir Immune Defic Syndr 1990; 3:873-6.
16. Fuchs D, Möller AA, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol Letters 1991; 28: 207-12.
17. Rudzite V, Skards JI, Fuchs D, Reibnegger G, Wachter H. Serum kynurenine and neopterin concentrations in patients with cardiomyopathy. Immunol Letters 1992; 32:125-30.
18. Weiss G, Fuchs D, Hausen A et al. Neopterin modulates toxicity mediated by reactive oxygen and chlorine species. FEBS Letters 1993; 321:89-92.
19. Fuchs D, Baier-Bitterlich G, Wede I, Wachter H. Reactive oxygen and apoptosis. In: Scandalios J, ed. Oxidative stress and the molecular biology of antioxidant defenses. New York: Cold Spring Harbor Press, 1997:139-67.
20. Hofmann G, Frede S, Kenn S et al. Neopterin-induced tumor necrosis factor-α synthesis in vascular smooth muscle cells in vitro. Int Arch Allergy Immunol 1998; 116:240-5.
21. Munn DH, Zhou M, Attwood JT, Nondarev I, Conway SJ, Marshall B, Brown C, Mellor AL. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281:1191-3.
22. Romagnani S. The Th1-Th2 paradigm. Immunol Today 1997; 18:263-6.
23. Trinchieri G. Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 1993; 14:335-8.
24. Trembleau S, Germann T, Gately MK, Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 1995; 16:383-6.
25. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC, Clin Chem 1997; 43:2324-6.
26. Weiss G, Werner-Felmayer G, Werner ER, Grünewald K, Wachter H, Hentze MW. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med 1994; 180:969-76.
27. Lester MR, Hofer MF, Gately M, Trumble A, Leung DY. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol 1995; 154:6174-81.
28. Klebanoff SJ. Oxygen metabolites from phagocytes. In: Gallin JI, Goldstein IM, eds. Inflammation - basic principles and clinical correlates. New York: Raven Press, 1992: 541-88.